At Allinaire Therapeutics,it identified a novel target to halt the progression of Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.
Allinaire Therapeutics
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.allinaire.com
Founded2015
Disease Focus
Development StageDiscovery
STOCK CODENon Listed
AddressBioMotiv 20600 Chagrin Boulevard, Suite 210, OH-44122ClevelandUnited States
BioMotiv 20600 Chagrin Boulevard, Suite 210, OH-44122
Cleveland
United States
Contact Number+2164553200
+2164553200
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]